facebook
twitter
Login
Register
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Login
Register
Select Your Interest
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
Login
Register
Home
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Home
News
Johnson and Johnson arm Janssen to discontinue Hepatitis C development program
US tribal patent deal could have big impact on generic drug market
Bristols drug cocktail cuts kidney cancer death risk 37 percent
Lupin to add GLP 1 analog to its diabetes portfolio in India
Glenmark gets USFDA approval for Rythmol SR generic
Panacea Biotec extends distribution pact with Canadian firm for US
Teva to sell contraceptive brand Paragard in 1.1 billion dollar deal
AbbVie says deaths in arthritis trial not linked to drug
Regeneron, Sanofi asthma drug data fails to excite investors
Strides Shasun gets USFDA nod for kidney stone tablets
Sanofi launches Combiflam Icyhot pain relief topical in India
Novartis posts a win, Roche a flop in skin cancer trials
Prev
Next
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our
Cookie Policy
and
Cookie Settings.
Ok